Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #21 to #520.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  2. Equivalent dose‏‎ (11 revisions)
  3. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  4. Absorbed dose‏‎ (9 revisions)
  5. Objectives of Radiological Protection‏‎ (9 revisions)
  6. Air-kerma rate constant‏‎ (9 revisions)
  7. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  8. Effects of Exposure‏‎ (8 revisions)
  9. Prudence‏‎ (8 revisions)
  10. Beneficence‏‎ (8 revisions)
  11. Organ/tissue absorbed dose‏‎ (8 revisions)
  12. Collective effective dose‏‎ (7 revisions)
  13. ICRPædia Guides‏‎ (6 revisions)
  14. Justice‏‎ (6 revisions)
  15. Accelerated fractionation‏‎ (6 revisions)
  16. Linear energy transfer‏‎ (6 revisions)
  17. Exposure Categories and Situations‏‎ (6 revisions)
  18. Investigation level‏‎ (6 revisions)
  19. Alimentary tract‏‎ (6 revisions)
  20. Absorbed fraction‏‎ (5 revisions)
  21. Justification‏‎ (5 revisions)
  22. Protection quantities‏‎ (5 revisions)
  23. Kerma‏‎ (5 revisions)
  24. Types of materials‏‎ (5 revisions)
  25. Radiation weighting factor‏‎ (5 revisions)
  26. Air-kerma, entrance surface‏‎ (5 revisions)
  27. Sources of Radiation Exposure‏‎ (5 revisions)
  28. Quality factor‏‎ (5 revisions)
  29. Dose coefficient‏‎ (5 revisions)
  30. Principle of optimisation‏‎ (5 revisions)
  31. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  32. Bioassay‏‎ (4 revisions)
  33. Calculating Radon Doses‏‎ (4 revisions)
  34. Computed tomography dose index‏‎ (4 revisions)
  35. Direct bioassay‏‎ (4 revisions - redirect page)
  36. Mass median diameter‏‎ (4 revisions)
  37. Alpha decay‏‎ (4 revisions)
  38. Math‏‎ (4 revisions)
  39. Programmed cell death‏‎ (4 revisions)
  40. Effective charge number‏‎ (4 revisions)
  41. Averted dose‏‎ (4 revisions)
  42. Effective half-life‏‎ (4 revisions)
  43. Protective action‏‎ (4 revisions)
  44. Reference Animal and Plant‏‎ (4 revisions)
  45. Kp index‏‎ (4 revisions)
  46. Forbiddenness‏‎ (4 revisions)
  47. Aerodynamic diameter‏‎ (4 revisions)
  48. ICRP‏‎ (4 revisions)
  49. Source-related assessment‏‎ (4 revisions)
  50. Reference bioassay function‏‎ (4 revisions)
  51. Diagnostic reference level‏‎ (4 revisions)
  52. Risk‏‎ (4 revisions)
  53. Senescence‏‎ (4 revisions)
  54. Air-kerma, product‏‎ (4 revisions)
  55. Fractionation sensitivity‏‎ (4 revisions)
  56. Optimisation‏‎ (4 revisions)
  57. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  58. Sievert‏‎ (4 revisions)
  59. Non-maleficence‏‎ (4 revisions)
  60. High linear energy transfer radiation‏‎ (4 revisions)
  61. S coefficient (radiation weighted)‏‎ (4 revisions)
  62. Growth fraction‏‎ (3 revisions)
  63. Organ dose equivalent‏‎ (3 revisions)
  64. Extrathoracic airways‏‎ (3 revisions)
  65. Galactic cosmic radiation‏‎ (3 revisions)
  66. Growth hormone (somatotropin)‏‎ (3 revisions)
  67. ICRP Publication 103‏‎ (3 revisions)
  68. Excretion rate (instantaneous)‏‎ (3 revisions)
  69. Fairness‏‎ (3 revisions)
  70. Absorption‏‎ (3 revisions)
  71. Gamma ray‏‎ (3 revisions)
  72. Recovery‏‎ (3 revisions)
  73. DNA damage signalling‏‎ (3 revisions)
  74. Spread-out Bragg peak‏‎ (3 revisions)
  75. Field-size effect (Volume effect)‏‎ (3 revisions)
  76. Gastrointestinal syndrome‏‎ (3 revisions)
  77. Wisdom‏‎ (3 revisions)
  78. Biomedical research volunteer‏‎ (3 revisions)
  79. Cardiomyopathy‏‎ (3 revisions)
  80. Dose equivalent‏‎ (3 revisions)
  81. Flexible tissues‏‎ (3 revisions)
  82. Guide to the System of Radiological Protection‏‎ (3 revisions)
  83. Autonomy‏‎ (3 revisions)
  84. Dose limit‏‎ (3 revisions)
  85. Target region‏‎ (3 revisions)
  86. Fluence‏‎ (3 revisions)
  87. Constancy test‏‎ (3 revisions)
  88. Dose‏‎ (3 revisions)
  89. Dose limits‏‎ (3 revisions)
  90. Fluoroscopically guided interventions‏‎ (3 revisions)
  91. Annual dose‏‎ (3 revisions)
  92. Potential exposure‏‎ (3 revisions)
  93. DS02‏‎ (3 revisions)
  94. Accountability‏‎ (3 revisions)
  95. X ray‏‎ (3 revisions)
  96. Half-life, physical‏‎ (3 revisions)
  97. Cell death‏‎ (3 revisions)
  98. Contamination‏‎ (3 revisions)
  99. Rigidity threshold‏‎ (3 revisions)
  100. Dose of record (E)‏‎ (3 revisions)
  101. Low Earth orbit‏‎ (3 revisions)
  102. Exponential survival curve‏‎ (3 revisions)
  103. Unsealed source‏‎ (3 revisions)
  104. Xerostomia‏‎ (3 revisions)
  105. Annual limit on intake‏‎ (3 revisions)
  106. Graded approach‏‎ (3 revisions)
  107. Public exposure‏‎ (3 revisions)
  108. Dose per content function‏‎ (3 revisions)
  109. Interphase death‏‎ (3 revisions)
  110. Equity‏‎ (3 revisions)
  111. Test‏‎ (3 revisions)
  112. Fractionation‏‎ (3 revisions)
  113. Uptake‏‎ (3 revisions)
  114. Active (red) bone marrow‏‎ (3 revisions)
  115. Utilitarian ethics‏‎ (3 revisions)
  116. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  117. Operational quantity‏‎ (3 revisions)
  118. Value judgement‏‎ (3 revisions)
  119. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  120. Coster-Kronig transition‏‎ (3 revisions)
  121. Valvular heart disease‏‎ (3 revisions)
  122. Gray‏‎ (3 revisions)
  123. Personal dose equivalent‏‎ (3 revisions)
  124. Principle of justification‏‎ (3 revisions)
  125. Radiofrequency ablation‏‎ (3 revisions)
  126. Emergency preparedness‏‎ (3 revisions)
  127. Absolute risk‏‎ (3 revisions)
  128. Virtue ethics‏‎ (3 revisions)
  129. Auger transition‏‎ (3 revisions)
  130. Bystander effect‏‎ (3 revisions)
  131. Iso-effect plots‏‎ (3 revisions)
  132. Emergency procedures‏‎ (3 revisions)
  133. Lifetime risk estimates‏‎ (3 revisions)
  134. Activity median thermodynamic diameter‏‎ (3 revisions)
  135. Voxel phantom‏‎ (3 revisions)
  136. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  137. Complex tissues‏‎ (3 revisions)
  138. Derived air concentration‏‎ (3 revisions)
  139. Dignity‏‎ (3 revisions)
  140. Isomers‏‎ (3 revisions)
  141. Employer‏‎ (3 revisions)
  142. Exposure to Radon at Home‏‎ (2 revisions)
  143. Transparency‏‎ (2 revisions)
  144. GATA binding protein 2‏‎ (2 revisions)
  145. Waste disposal‏‎ (2 revisions)
  146. Non-targeted effects‏‎ (2 revisions)
  147. Hormones‏‎ (2 revisions)
  148. Authorization‏‎ (2 revisions)
  149. Procedural values‏‎ (2 revisions)
  150. Clonogenic cells‏‎ (2 revisions)
  151. Curie‏‎ (2 revisions)
  152. Reproductive integrity‏‎ (2 revisions)
  153. Safety case‏‎ (2 revisions)
  154. Slow repair‏‎ (2 revisions)
  155. Effect Dose 50‏‎ (2 revisions)
  156. Isotropic geometry‏‎ (2 revisions)
  157. Endogeneous excretion‏‎ (2 revisions)
  158. Lineal energy‏‎ (2 revisions)
  159. Thyroid blocking‏‎ (2 revisions)
  160. Trapped particles‏‎ (2 revisions)
  161. Acute radiation syndrome‏‎ (2 revisions)
  162. Orphan source‏‎ (2 revisions)
  163. Hounsfield unit‏‎ (2 revisions)
  164. Authorized limit‏‎ (2 revisions)
  165. Planned exposure situation‏‎ (2 revisions)
  166. Progenitor cell‏‎ (2 revisions)
  167. Cardiac arrhythmias‏‎ (2 revisions)
  168. Radiation belt‏‎ (2 revisions - redirect page)
  169. Clonogenic survival‏‎ (2 revisions)
  170. Reasonableness‏‎ (2 revisions)
  171. Cytokines‏‎ (2 revisions)
  172. Residual dose‏‎ (2 revisions)
  173. Safety culture‏‎ (2 revisions)
  174. Solar cosmic radiation‏‎ (2 revisions)
  175. Inhalability‏‎ (2 revisions)
  176. Spontaneous fission‏‎ (2 revisions)
  177. Itinerant (radiation) worker‏‎ (2 revisions)
  178. Linear-non-threshold model‏‎ (2 revisions)
  179. Time factor‏‎ (2 revisions)
  180. Myocardial perfusion‏‎ (2 revisions)
  181. Adaptive response‏‎ (2 revisions)
  182. What is Radon?‏‎ (2 revisions)
  183. Alveolar-interstitial region‏‎ (2 revisions)
  184. Autoimmune disease‏‎ (2 revisions)
  185. Platelet-derived growth factor‏‎ (2 revisions)
  186. ICRP Publication 118‏‎ (2 revisions)
  187. Cardiac valve diseases‏‎ (2 revisions)
  188. Radiation modifier‏‎ (2 revisions)
  189. Radiological protection principles‏‎ (2 revisions)
  190. Respiratory protection‏‎ (2 revisions)
  191. Disposal‏‎ (2 revisions)
  192. Scintigraphy‏‎ (2 revisions)
  193. Dose criteria‏‎ (2 revisions)
  194. Solar cycle‏‎ (2 revisions)
  195. Inner bremsstrahlung‏‎ (2 revisions)
  196. Environmental exposure‏‎ (2 revisions)
  197. Systemic model‏‎ (2 revisions)
  198. Linear-quadratic dose response model‏‎ (2 revisions)
  199. Exempt waste‏‎ (2 revisions)
  200. Tissue equivalent material‏‎ (2 revisions)
  201. Myocardial stress test‏‎ (2 revisions)
  202. Oversight‏‎ (2 revisions)
  203. Projected dose‏‎ (2 revisions)
  204. Co-expertise‏‎ (2 revisions)
  205. Radionuclides of natural origin‏‎ (2 revisions)
  206. Connective tissue‏‎ (2 revisions)
  207. Recovery (cellular or tissue)‏‎ (2 revisions)
  208. DRL process‏‎ (2 revisions)
  209. Retrievability‏‎ (2 revisions)
  210. Immune system‏‎ (2 revisions)
  211. Institutional control‏‎ (2 revisions)
  212. Stakeholder‏‎ (2 revisions)
  213. Environmental radiation protection‏‎ (2 revisions)
  214. Tachycardia‏‎ (2 revisions)
  215. Exemption level‏‎ (2 revisions)
  216. Existing exposure situation‏‎ (2 revisions)
  217. Gastroschisis‏‎ (2 revisions)
  218. Worker‏‎ (2 revisions)
  219. Nuclear track detectors‏‎ (2 revisions)
  220. Angiogenesis‏‎ (2 revisions)
  221. Hyperbaric oxygen‏‎ (2 revisions)
  222. Bioturbation‏‎ (2 revisions)
  223. Cardioverter-defibrillator‏‎ (2 revisions)
  224. Radiation safety officer‏‎ (2 revisions)
  225. Radioresponsiveness‏‎ (2 revisions)
  226. Consequential late effects‏‎ (2 revisions)
  227. Recovery responder‏‎ (2 revisions)
  228. Reversibility‏‎ (2 revisions)
  229. In vivo radiobioassay‏‎ (2 revisions)
  230. Solar particle event‏‎ (2 revisions)
  231. Effective dose equivalent‏‎ (2 revisions)
  232. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  233. Acceptance test‏‎ (2 revisions)
  234. Gastrulation‏‎ (2 revisions)
  235. Working level‏‎ (2 revisions)
  236. OLINDA/EXM‏‎ (2 revisions)
  237. Habitual mouth breather‏‎ (2 revisions)
  238. Annihilation photons‏‎ (2 revisions)
  239. Particle radiance‏‎ (2 revisions)
  240. Hyperfractionation‏‎ (2 revisions)
  241. Bone marrow‏‎ (2 revisions)
  242. Protection strategy‏‎ (2 revisions)
  243. Radiation source‏‎ (2 revisions)
  244. Cohort study‏‎ (2 revisions)
  245. Radiosensitiser‏‎ (2 revisions)
  246. DRL value‏‎ (2 revisions)
  247. Rehabilitation of living conditions‏‎ (2 revisions)
  248. Right to know‏‎ (2 revisions)
  249. Incidence‏‎ (2 revisions)
  250. Solar wind‏‎ (2 revisions)
  251. Epithelium‏‎ (2 revisions)
  252. Target tissue‏‎ (2 revisions)
  253. Expanded and aligned radiation field‏‎ (2 revisions)
  254. Tolerability‏‎ (2 revisions)
  255. Medical exposure‏‎ (2 revisions)
  256. Naturally occurring radioactive material‏‎ (2 revisions)
  257. Adventitious‏‎ (2 revisions)
  258. Working level month‏‎ (2 revisions)
  259. Habitual nose breather‏‎ (2 revisions)
  260. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  261. Background dose (rate)‏‎ (2 revisions)
  262. Radiosensitivity, cellular‏‎ (2 revisions)
  263. Containment‏‎ (2 revisions)
  264. Rigidity‏‎ (2 revisions)
  265. Dose-length product‏‎ (2 revisions)
  266. Security‏‎ (2 revisions)
  267. Incident‏‎ (2 revisions)
  268. Intermediate level waste‏‎ (2 revisions)
  269. Stenosis‏‎ (2 revisions)
  270. Equieffective dose‏‎ (2 revisions)
  271. Local DRL‏‎ (2 revisions)
  272. Member of the public‏‎ (2 revisions)
  273. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  274. Unattached fraction‏‎ (2 revisions)
  275. Necrosis‏‎ (2 revisions)
  276. Patient entrance reference point‏‎ (2 revisions)
  277. Hypoplasia‏‎ (2 revisions)
  278. Backscatter detection system‏‎ (2 revisions)
  279. Potential recoverability correction factor‏‎ (2 revisions)
  280. Bradycardia‏‎ (2 revisions)
  281. Protective action guide‏‎ (2 revisions)
  282. Radiation worker‏‎ (2 revisions)
  283. Detriment‏‎ (2 revisions)
  284. Dose-rate effect‏‎ (2 revisions)
  285. Inclusiveness‏‎ (2 revisions)
  286. Source-related‏‎ (2 revisions)
  287. Internal conversion electron‏‎ (2 revisions)
  288. Electron-capture decay‏‎ (2 revisions)
  289. LD 50/30‏‎ (2 revisions)
  290. Telangiectasia‏‎ (2 revisions)
  291. Track structure‏‎ (2 revisions)
  292. Mendelian diseases‏‎ (2 revisions)
  293. Accreditation‏‎ (2 revisions)
  294. Neurological syndrome‏‎ (2 revisions)
  295. Genomic integrity‏‎ (2 revisions)
  296. Occupational exposure‏‎ (2 revisions)
  297. Hazard‏‎ (2 revisions)
  298. Peak skin dose‏‎ (2 revisions)
  299. Bragg peak‏‎ (2 revisions)
  300. Radioactive dispersion device‏‎ (2 revisions)
  301. Radon: Units of Measure‏‎ (2 revisions)
  302. Coronary heart disease‏‎ (2 revisions)
  303. Reference air kerma‏‎ (2 revisions)
  304. Decay constant‏‎ (2 revisions)
  305. Self-help protection‏‎ (2 revisions)
  306. Individual-related‏‎ (2 revisions)
  307. Dose of record Hp (10)‏‎ (2 revisions)
  308. Electrophysiology‏‎ (2 revisions)
  309. Storage‏‎ (2 revisions)
  310. Transfer compartment‏‎ (2 revisions)
  311. Mitigation‏‎ (2 revisions)
  312. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  313. Action Level‏‎ (2 revisions)
  314. Upper reference levels‏‎ (2 revisions)
  315. Neurovascular syndrome‏‎ (2 revisions)
  316. Health Surveillance‏‎ (2 revisions)
  317. Pelagic‏‎ (2 revisions)
  318. Basal cell‏‎ (2 revisions)
  319. Practical radiological protection culture‏‎ (2 revisions)
  320. Branching fraction‏‎ (2 revisions)
  321. Chronic exposure‏‎ (2 revisions)
  322. Radioactive source‏‎ (2 revisions)
  323. Colony‏‎ (2 revisions)
  324. Cosmic Radiation in Aviation‏‎ (2 revisions)
  325. Decommissioning‏‎ (2 revisions)
  326. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  327. Dose-threshold‏‎ (2 revisions)
  328. Individual decontamination‏‎ (2 revisions)
  329. Subcutaneous tissue‏‎ (2 revisions)
  330. Low dose rate‏‎ (2 revisions)
  331. Exposure, external or internal‏‎ (2 revisions)
  332. Graft vs host disease‏‎ (2 revisions)
  333. Air-kerma, incident‏‎ (2 revisions)
  334. Heliosphere‏‎ (2 revisions)
  335. Qualified expert‏‎ (2 revisions)
  336. Class SR-0 gases‏‎ (2 revisions)
  337. Radioactive substance‏‎ (2 revisions)
  338. Reference biokinetic model‏‎ (2 revisions)
  339. Decontamination‏‎ (2 revisions)
  340. Relocation‏‎ (2 revisions)
  341. Diastasis‏‎ (2 revisions)
  342. Risk coefficient‏‎ (2 revisions)
  343. Individual monitoring‏‎ (2 revisions)
  344. Dose per unit intake coefficient‏‎ (2 revisions)
  345. Source term‏‎ (2 revisions)
  346. Emergency‏‎ (2 revisions)
  347. Latent time/period or latency interval‏‎ (2 revisions)
  348. Low level waste‏‎ (2 revisions)
  349. Exposure (in the context of inhalation)‏‎ (2 revisions)
  350. Transfer rate‏‎ (2 revisions)
  351. Multi-detector computed tomography‏‎ (2 revisions)
  352. Fractionation and dose delivery patterns‏‎ (2 revisions)
  353. Percutaneous coronary intervention‏‎ (2 revisions)
  354. Prevailing circumstances‏‎ (2 revisions)
  355. Broad beam therapy irradiation technique‏‎ (2 revisions)
  356. Class SR-1 gases‏‎ (2 revisions)
  357. Committed effective dose‏‎ (2 revisions)
  358. Radon Recommendations for Authorities‏‎ (2 revisions)
  359. Cost-benefit analysis‏‎ (2 revisions)
  360. Reference individual‏‎ (2 revisions)
  361. Decontamination factor‏‎ (2 revisions)
  362. Remedial action‏‎ (2 revisions)
  363. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  364. Dose rate‏‎ (2 revisions)
  365. Intervention Level‏‎ (2 revisions)
  366. Emergency exposure situation‏‎ (2 revisions)
  367. Substantial radiation dose level‏‎ (2 revisions)
  368. Erythropoietin‏‎ (2 revisions)
  369. ALARA‏‎ (2 revisions)
  370. Transforming growth factor‏‎ (2 revisions)
  371. Hierarchical tissues‏‎ (2 revisions)
  372. Area monitoring‏‎ (2 revisions)
  373. Pericarditis‏‎ (2 revisions)
  374. Benthic‏‎ (2 revisions)
  375. Principle of application of dose limits‏‎ (2 revisions)
  376. Bronchial region‏‎ (2 revisions)
  377. Class SR-2 gases‏‎ (2 revisions)
  378. Radioactivity‏‎ (2 revisions)
  379. Committed equivalent dose‏‎ (2 revisions)
  380. Radon Recommendations for Workplaces‏‎ (2 revisions)
  381. Reference level‏‎ (2 revisions)
  382. Remediation‏‎ (2 revisions)
  383. Dichotomous‏‎ (2 revisions)
  384. Risk of Exposure to Radon‏‎ (2 revisions)
  385. Dose rate effectiveness factor‏‎ (2 revisions)
  386. South Atlantic anomaly‏‎ (2 revisions)
  387. Interventional procedure‏‎ (2 revisions)
  388. Emergency plan‏‎ (2 revisions)
  389. Ethics‏‎ (2 revisions)
  390. Lymphatic system‏‎ (2 revisions)
  391. Multiplicative risk projection model‏‎ (2 revisions)
  392. Activity‏‎ (2 revisions)
  393. High level waste‏‎ (2 revisions)
  394. Clearance‏‎ (2 revisions)
  395. Deontological Ethics‏‎ (2 revisions)
  396. Repopulation‏‎ (2 revisions)
  397. Differentiation‏‎ (2 revisions)
  398. Routine monitoring‏‎ (2 revisions)
  399. ICRPædia Guide to Radon‏‎ (2 revisions)
  400. Special (non-routine) monitoring‏‎ (2 revisions)
  401. Lifetime risk‏‎ (2 revisions)
  402. Macrophage colony stimulating factor‏‎ (2 revisions)
  403. Beta-minus decay‏‎ (2 revisions)
  404. Clearance level‏‎ (2 revisions)
  405. Radiographer‏‎ (2 revisions)
  406. Representative organism (non-human biota)‏‎ (2 revisions)
  407. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  408. Dose constraint‏‎ (2 revisions)
  409. Early normal tissue responses‏‎ (2 revisions)
  410. Threshold dose for tissue reactions‏‎ (2 revisions)
  411. Magnetosphere‏‎ (2 revisions)
  412. Exposure situation‏‎ (2 revisions)
  413. Transmission detection system‏‎ (2 revisions)
  414. Multistage tumorigenesis‏‎ (2 revisions)
  415. Non-sphericity parameter‏‎ (2 revisions)
  416. Growth factor‏‎ (2 revisions)
  417. Alimentary tract transfer factor‏‎ (2 revisions)
  418. Pharynx‏‎ (2 revisions)
  419. Beta-plus decay‏‎ (2 revisions)
  420. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  421. Cumulative dose‏‎ (2 revisions)
  422. Representative person‏‎ (2 revisions)
  423. Safety‏‎ (2 revisions)
  424. Dose conversion coefficient‏‎ (2 revisions)
  425. Edema‏‎ (2 revisions)
  426. Specific effective energy‏‎ (2 revisions)
  427. Limitation of dose‏‎ (2 revisions)
  428. Excess relative risk‏‎ (2 revisions)
  429. Marrow cellularity‏‎ (1 revision)
  430. Multitarget equation‏‎ (1 revision)
  431. Acute exposure‏‎ (1 revision)
  432. Allometry‏‎ (1 revision)
  433. Pilomatricoma‏‎ (1 revision)
  434. ICRP Publication 102‏‎ (1 revision)
  435. ICRP Publication 116‏‎ (1 revision)
  436. Radiation-induced secondary malignancy‏‎ (1 revision)
  437. ICRP Publication 130‏‎ (1 revision)
  438. Radiological attack‏‎ (1 revision)
  439. ICRP Publication 145‏‎ (1 revision)
  440. Reactive oxygen species‏‎ (1 revision)
  441. ICRP Publication 2‏‎ (1 revision)
  442. Reference worker‏‎ (1 revision)
  443. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  444. Derived consideration reference level‏‎ (1 revision)
  445. ICRP Publication 92‏‎ (1 revision)
  446. ICRP Publication 40‏‎ (1 revision)
  447. ICRP Publication 55‏‎ (1 revision)
  448. Dose conversion convention‏‎ (1 revision)
  449. Informed consent‏‎ (1 revision)
  450. ICRP Publication 7‏‎ (1 revision)
  451. Spongiosa‏‎ (1 revision)
  452. ICRP Publication 84‏‎ (1 revision)
  453. Exclusion‏‎ (1 revision)
  454. Time-resolved computed tomography‏‎ (1 revision)
  455. Mutation component‏‎ (1 revision)
  456. Waste management‏‎ (1 revision)
  457. Normal tissue complication probability‏‎ (1 revision)
  458. Biological half-life‏‎ (1 revision)
  459. ICRP Publication 117‏‎ (1 revision)
  460. ICRP Publication 131‏‎ (1 revision)
  461. Radiological controlled area‏‎ (1 revision)
  462. ICRP Publication 146‏‎ (1 revision)
  463. Concentration ratio‏‎ (1 revision)
  464. ICRP Publication 20‏‎ (1 revision)
  465. Referrer‏‎ (1 revision)
  466. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  467. Derived investigation level‏‎ (1 revision)
  468. ICRP Publication 93‏‎ (1 revision)
  469. ICRP Publication 41‏‎ (1 revision)
  470. Directional dose equivalent‏‎ (1 revision)
  471. ICRU 4-element tissue‏‎ (1 revision)
  472. ICRP Publication 56‏‎ (1 revision)
  473. Dose conversion factor‏‎ (1 revision)
  474. ICRP Publication 70‏‎ (1 revision)
  475. Effect modifier‏‎ (1 revision)
  476. ICRP Publication 85‏‎ (1 revision)
  477. Endosteum‏‎ (1 revision)
  478. System of radiological protection‏‎ (1 revision)
  479. Treatment preparation in radiotherapy‏‎ (1 revision)
  480. Notification value‏‎ (1 revision)
  481. Other (systemic) tissues‏‎ (1 revision)
  482. Human Alimentary Tract Model‏‎ (1 revision)
  483. ICRP Publication 104‏‎ (1 revision)
  484. Biomarker‏‎ (1 revision)
  485. ICRP Publication 132‏‎ (1 revision)
  486. Clonogenic surviving fraction‏‎ (1 revision)
  487. ICRP Publication 147‏‎ (1 revision)
  488. Cone beam computed tomography‏‎ (1 revision)
  489. ICRP Publication 21‏‎ (1 revision)
  490. Region‏‎ (1 revision)
  491. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  492. Derived limit‏‎ (1 revision)
  493. ICRP Publication 94‏‎ (1 revision)
  494. ICRP Publication 42‏‎ (1 revision)
  495. ICRU sphere‏‎ (1 revision)
  496. ICRP Publication 57‏‎ (1 revision)
  497. ICRP Publication 71‏‎ (1 revision)
  498. ICRP Publication 86‏‎ (1 revision)
  499. Mean glandular dose‏‎ (1 revision)
  500. Absorption Type‏‎ (1 revision - redirect page)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:MostRevisions"